The cardiac surgical devices market size is USD 2.8 Bn in 2026.
The cardiac surgical devices market is projected to grow at a CAGR of 4% by 2033.
The cardiac surgical devices market growth drivers include rising prevalence of cardiovascular diseases, increasing diabetic and geriatric population, and sedentary lifestyles.
North America is the dominating region for cardiac surgical devices market.
Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, and Edwards Lifesciences Corporation are some leading industry players in the cardiac surgical devices market.